HUNTINGTON NATIONAL BANK - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 195 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$24,000
+500.0%
190
+280.0%
0.00%
Q2 2019$4,000
-33.3%
500.0%0.00%
Q1 2019$6,000
+20.0%
500.0%0.00%
Q4 2018$5,000
-16.7%
500.0%0.00%
Q3 2018$6,000
+50.0%
500.0%0.00%
Q2 2018$4,000
+33.3%
500.0%0.00%
Q1 2018$3,0000.0%500.0%0.00%
Q4 2017$3,0000.0%500.0%0.00%
Q3 2017$3,000
-50.0%
500.0%0.00%
Q2 2017$6,0000.0%500.0%0.00%
Q1 2017$6,000
+20.0%
500.0%0.00%
Q4 2016$5,000
-37.5%
500.0%0.00%
Q3 2016$8,000
+14.3%
500.0%0.00%
Q2 2016$7,000
-50.0%
500.0%0.00%
Q1 2016$14,000
+100.0%
500.0%0.00%
Q4 2015$7,000
-12.5%
500.0%0.00%
Q3 2015$8,000
-33.3%
500.0%0.00%
Q2 2015$12,000
-14.3%
500.0%0.00%
Q1 2015$14,000
+75.0%
500.0%0.00%
Q4 2014$8,000500.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders